Companies / Australia
Biotech Sector Eyes Expansion
November 2006 | Industry NewsLeading Australian biotech CSL - the world's largest maker of blood plasma products - is to acquire transplant medicine CytoGam from US firm MedImmune for some US$120mn. The addition to CSL's portfolio comes at a time when the country's biotechs are showing increasing confidence on a global scale, as the need to expand becomes
To read the full article, please choose one of the following options:
Subcribers please log in
